-+ 0.00%
-+ 0.00%
-+ 0.00%

ACUMEN PHARMACEUTICALS SHARES DOWN 77.3% TO $0.52 PREMARKET AFTER CO'S ALZHEIMER'S DRUG MISSES PRIMARY ENDPOINT IN MID-STAGE TRIAL

路透·10/30/2026 11:43:57

请登录查看新闻详情